Advanced Biomed Inc. (ADVB) Stock

Healthcare · Diagnostics & Research · Member of Other US Stocks

Advanced Biomed Inc. (ADVB) closed at USD 5.14 on 2026-10-14, a change of -41.7 % over the past year, with a market capitalization of USD 8.06M.

Advanced Biomed Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Advanced Biomed Inc. key figures

Previous close

USD 5.14 (2026-10-14)

1-year change

-41.7 %

Market cap

USD 8.06M

Enterprise value

USD 8.76M

P/E ratio (trailing)

1.07

P/E ratio (forward)

n/a

EPS (trailing)

4.57

EPS (forward)

n/a

PEG ratio

n/a

Price to book

0.66

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.28

Employees

n/a

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Advanced Biomed Inc.

Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan. It offers A+Pre, a device that prepares blood samples for testing; the AC-1000, a device that separates cancer cells from the rest of the blood; A+SCDrop, a device that isolates individual cells; and A+CellScan, a device that stains and automatically counts cancer cells. The company provides developed dye kits used to identify different types of cancer cells. It also offers FinTruth financial verification agent platform, an enterprise AI financial verification platform designed to compare and verify financial analysis and AI-generated financial content against underlying source documents and financial rules, and to produce source-traceable and auditable results. The company was founded in 2014 and is based in Tsuen Wan, Hong Kong.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Advanced Biomed Inc. and compare it with other stocks.